<?xml version="1.0" encoding="UTF-8"?>
<ref id="B79-pharmaceuticals-12-00147">
 <label>79.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gerlach</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Hensen</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Matrosovich</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Bergmann</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Winkler</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Peteranderl</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Klenk</surname>
    <given-names>H.D.</given-names>
   </name>
   <name>
    <surname>Weber</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Herold</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Pohlmann</surname>
    <given-names>S.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenza A Viruses to the Interferon-Induced Antiviral State and IFITMs</article-title>
  <source>J. Virol.</source>
  <year>2017</year>
  <volume>91</volume>
  <fpage>e00246-17</fpage>
  <pub-id pub-id-type="doi">10.1128/JVI.00246-17</pub-id>
  <pub-id pub-id-type="pmid">28356532</pub-id>
 </element-citation>
</ref>
